ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs – Xconomy

Continue reading

2018-01-11 Michael Zand NEWS

Genedata Announces New Solution for CRISPR Data Management and Analysis – Benzinga

Genedata Announces New Solution for CRISPR Data Management and AnalysisBenzingaGenedata, a leading provider of advanced software solutions for R&D, today announced the release of Genedata Selector for Precise Genome Editing, an innovative solution … Continue reading

2018-01-11 Michael Zand NEWS

Few Patients Get CAR T Cells Because of ‘Insurance Snags’ – Medscape


Xconomy

Notes From the JPM ’18 Vortex: Gene Therapy’s Reckoning and Lonely Cabs
Xconomy
The annual J.P. Morgan Healthcare conference in San Francisco winds down today, meaning the remaining stragglers are either presenting to half-empty rooms or headed back to colder climes. Compared to a 2017 full of scientific milestones—FDA approvals …

Continue reading

2018-01-11 Michael Zand NEWS

Few Patients Get CAR T Cells Because of ‘Insurance Snags’ – Medscape


Medscape

Few Patients Get CAR T Cells Because of ‘Insurance Snags’
Medscape
Although clinical responses have been remarkable and the approval by the US Food and Drug Administration (FDA) of these novel therapies was heralded as the biggest medical news of last year, it appears that chimeric antigen receptor (CAR) T-cell …

Continue reading

2018-01-11 Michael Zand NEWS

Few Patients Get CAR T Cells Because of ‘Insurance Snags’ – Medscape

Few Patients Get CAR T Cells Because of ‘Insurance Snags’
Medscape
Although clinical responses have been remarkable and the approval by the US Food and Drug Administration (FDA) of these novel therapies was heralded as the biggest medical news of last year, it appears that chimeric antigen receptor (CAR) T-cell …

Continue reading

2018-01-11 Michael Zand NEWS

New Cancer Treatments Top $500000, Raise Daunting Questions About How To Pay – WBUR

Few Patients Get CAR T Cells Because of ‘Insurance Snags’
Medscape
Although clinical responses have been remarkable and the approval by the US Food and Drug Administration (FDA) of these novel therapies was heralded as the biggest medical news of last year, it appears that chimeric antigen receptor (CAR) T-cell …

Continue reading

2018-01-11 Michael Zand NEWS

CRISPR-Cas: Genetic engineering’s Holy Grail – Independent


WBUR

New Cancer Treatments Top $500000, Raise Daunting Questions About How To Pay
WBUR
It’s one of the most effective cancer treatments so far. And one of the most expensive cancer drugs ever. That’s why cancer specialists are both excited about so-called CAR–T cell therapy — and worried about what it portends for the affordability of …

and more »

Continue reading

2018-01-11 Michael Zand NEWS

CRISPR Therapeutics: Elucidating The New CRISPR/Cas9 Exploratory Findings – Seeking Alpha

Seeking AlphaCRISPR Therapeutics: Elucidating The New CRISPR/Cas9 Exploratory FindingsSeeking AlphaOn Jan 09, 2018, the share price of CRISPR Therapeutics (NASDAQ:CRSP), a gene-editing and CAR-T-focused firm to service serious conditions like cancers a… Continue reading

2018-01-11 Michael Zand NEWS
  • 1
  • …
  • 677
  • 678
  • 679
  • 680
  • 681
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Independent

CRISPR-Cas: Genetic engineering’s Holy Grail
Independent
COMMENT | TECHNOLOGY | Antoine Danchin | Since its introduction four decades ago, genetic engineering has been a source of high hopes for health, agriculture, and industry. But it has also provoked deep anxiety, not least owing to the laborious nature …